Sort
15,273 grants matching “antimicrobial resistance”
Chemoenzymatic studies of aminoglycoside-resistance enzymes towards new drugs
$411,807Sylvie Garneau-Tsodikova · University Of Kentucky · R01 · FY2014 · AI
The Abeta protein of Alzheimer's Disease is an antimicrobial peptide
$411,791Robert D Moir · Massachusetts General Hospital · R01 · FY2013 · AI
Immune mechanisms that promote S. aureus persistence during craniotomy-associated biofilm infection
$411,762Tammy L Kielian · University Of Nebraska Medical Center · R01 · FY2018 · NS
Visualizing Effects of Costimulation on Antiviral Immunity
$411,538Arlene H Sharpe · Harvard Medical School · P01 · FY2012 · AI
Project 1
$411,483Beth Fuchs · Miriam Hospital · P20 · FY2020 · GM
Biologically Active Cyclic Peptides
$411,469Dale L Boger · Scripps Research Institute, The · R01 · FY2017 · CA
Biologically Active Cyclic Peptides
$411,469Dale L Boger · Scripps Research Institute, The · R01 · FY2018 · CA
Plasmid-mediated Quinolone Resistance
$411,320David C Hooper · Massachusetts General Hospital · R01 · FY2014 · AI
Activation of Macrophages in Human Autoimmune Diseases
$411,257Lionel B Ivashkiv · Hospital For Special Surgery · R01 · FY2021 · AI
Inducible epithelial resilience during pneumonia
$411,250Lee Quinton · Boston University Medical Campus · R01 · FY2017 · HL
Impact of Diabetes and Hyperlipidemia on Host Defense
$411,250Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2012 · HL
Impact of Diabetes and Hyperlipidemia on Host Defense
$411,250Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2011 · HL
Subproject 3: Unique Features of Enterococcus that Confer Intrinsic Resistance
$411,232Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2022 · AI
The roles of genes critical for growth in vitro
$411,169Dirk Schnappinger · Harvard School Of Public Health · U19 · FY2017 · AI
Francisella tularensis Pathogenesis
$411,130Thomas H Kawula · Washington State University · R01 · FY2019 · AI
Plasmid-mediated Quinolone resistance
$410,850David C Hooper · Massachusetts General Hospital · R01 · FY2011 · AI
An Integrated Device for Rapid Bacteremia Diagnosis from Whole Blood
$410,823Alon Singer · Helixbind, Inc. · R44 · FY2018 · AI
ALTERNATIVE APPROACHES FOR E FAECALIS INFECTIONS
$410,780Barbara E Murray · University Of Texas Hlth Sci Ctr Houston · R37 · FY2008 · AI
Theory Assisted Design, Synthesis and Biological Activity of Bacteria-Targeting Nanostructures
$410,713Martin Miguel Conda Sheridan · University Of Nebraska Medical Center · R01 · FY2025 · EB
Targeted Clinical Trials To Reduce the Risk of Antimicrobial Resistance
$410,665Alehandro Hoberman · University Of Pittsburgh At Pittsburgh · N01 · FY2013 · AI
Regulation of motility and organelle assembly at the Pseudomonas aeruginosa pole
$410,644Barbara I Kazmierczak · Yale University · R01 · FY2012 · AI
Integrated modeling of Klebsiella pneumoniae infections based on bacterial genotype, patient factors and colonization status
$410,599Michael Abbott Bachman · University Of Michigan At Ann Arbor · R01 · FY2020 · AI
GTPase control of large ribosome subunit biogenesis
$410,374Robert A Britton · Baylor College Of Medicine · R01 · FY2015 · GM
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
$410,368Marjana Tomic-Canic · University Of Miami School Of Medicine · R01 · FY2024 · DK
MICROBIOTA-DEPENDENT CONTROL OF CLOSTRIDIUM DIFFICILE: THE ROLE OF ACETATE AND IL-22 BINDING PROTEIN
$410,302Marco Colonna · Washington University · R01 · FY2023 · DK